LIVN
LivaNova PLC
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Neutral
+15/100
Last price
74.93
▼ 1.50 (1.96%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
76.90
Prev close
76.43
Day high
76.80
Day low
74.58
Volume
424.53K
Market cap
$4.12B
P/E (TTM)
22.17
52W range
48.82 – 85.76
Day trading desk
Gap from prior close
+0.62%
Prior close 76.43
VWAP
75.10
-0.22% from price
Relative volume
0.98×
Normal
Session range
4.42%
74.00 – 77.27
Position in range
28%
Near session low
ATR (14D)
2.14
2.85% of price
Prior day high
76.90
PDH
Prior day low
74.23
PDL
Bid / ask spread
—
Quote not published
Session volume
641.20K
Avg 651.64K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-2.68%
-4.6%
1M
-8.53%
-9.7%
3M
-9.19%
-13.7%
6M
+17.93%
-0.3%
YTD
+21.78%
+7.5%
1Y
+40.40%
+24.0%
3Y
+41.70%
-40.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on LIVN open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+39.07K
Net buying
Buy transactions
11
52.19K shares
Sell transactions
6
13.13K shares
Net transactions
+17
Buys less sells
Sell : buy shares
0.3 : 1
Mixed
Insider-held shares
228.09K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 10, 26 | BIANCHI FRANCESCO Director |
SELL | 3.50K | $273.03K | Direct |
| Sep 4, 26 | STORY BROOKE Director |
SELL | 2.30K | $187.27K | Direct |
| Aug 31, 26 | BIANCHI FRANCESCO Director |
SELL | 1.65K | $131.54K | Direct |
| Aug 11, 26 | TEZEL AHMET Officer |
CONVERSION | 12.69K | $668.62K | Direct |
| Aug 11, 26 | TEZEL AHMET Officer |
SELL | 2.67K | $207.94K | Direct |
| Jun 15, 26 | PODLOGAR SUSAN M Director |
— | 4.04K | — | Direct |
| Jun 15, 26 | BARRY JAMES CHRISTOPHER Director |
— | 4.04K | — | Direct |
| Jun 15, 26 | STORY BROOKE Director |
— | 4.04K | — | Direct |
| Jun 15, 26 | TEZEL AHMET Officer |
— | 2.96K | — | Direct |
| Jun 15, 26 | KOZY WILLIAM A Director |
— | 5.68K | — | Direct |
| Jun 15, 26 | SCHERMERHORN TODD C Director |
— | 4.04K | — | Direct |
| Jun 15, 26 | WILVER PETER M Director |
— | 4.04K | — | Direct |
| Jun 15, 26 | ENXING SENG STACY Director |
— | 4.04K | — | Direct |
| Jun 15, 26 | ZURBAY DONALD J Director |
— | 2.56K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BARRY JAMES CHRISTOPHER |
Director | 7.92K | Conversion of Exercise of derivative security |
BOLTON STEPHANIE |
Officer | 22.19K | Conversion of Exercise of derivative security |
ENXING SENG STACY |
Director | 15.31K | Conversion of Exercise of derivative security |
KOZY WILLIAM A |
Director | 37.57K | Conversion of Exercise of derivative security |
MAKATSARIA VLADIMIR A. |
Chief Executive Officer | 14.17K | Conversion of Exercise of derivative security |
O'KANE SHARON |
Director | 11.30K | Conversion of Exercise of derivative security |
POLETTI FRANCO |
Officer | 10.97K | Conversion of Exercise of derivative security |
SCHERMERHORN TODD C |
Director | 12.62K | Conversion of Exercise of derivative security |
SHVARTSBURG ALEX |
Chief Financial Officer | 44.65K | Conversion of Exercise of derivative security |
WILVER PETER M |
Director | 10.29K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$4.12B
Enterprise value$3.96B
Revenue (TTM)$1.47B
Gross profit$996.85M
EBITDA$260.14M
Net income$188.55M
EPS (TTM)$3.38
Free cash flow$59.87M
Total cash$516.62M
Total debt$351.95M
Book value / share$24.07
Shares outstanding54.93M
Float54.84M
Short % of float11.20%
Dividend yield0.00%
Beta (5Y)0.88
Valuation & profitability ratios
Trailing P/E22.17
Forward P/E16.00
PEG ratio0.93
Price / sales—
Price / book3.11
EV / revenue2.69
EV / EBITDA15.24
Gross margin67.74%
Operating margin13.54%
Profit margin12.81%
Return on equity15.40%
Return on assets5.04%
Debt / equity26.56
Current ratio1.45
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.39B | $1.25B | $1.15B | $1.02B | +10.7% |
| Operating revenue | $1.39B | $1.25B | $1.15B | $1.02B | +10.7% |
| Cost of revenue | $448.18M | $399.95M | $397.73M | $314.58M | +12.1% |
| Gross profit | $939.87M | $853.48M | $755.82M | $707.23M | +10.1% |
| Research & development | $185.76M | $182.51M | $193.82M | $155.81M | +1.8% |
| Selling, general & admin | $548.81M | $508.88M | $502.70M | $469.24M | +7.8% |
| Total operating expense | $740.48M | $724.43M | $734.34M | $654.58M | +2.2% |
| Operating income | $199.39M | $129.05M | $21.48M | $52.64M | +54.5% |
| Net interest income | -$30.30M | -$32.99M | -$36.84M | -$43.55M | +8.2% |
| Pre-tax income | -$220.78M | $88.31M | -$81.23M | -$75.14M | -350.0% |
| Tax provision | $21.64M | $25.06M | -$98.88M | $11.05M | -13.6% |
| Net income | -$242.47M | $63.23M | $17.55M | -$86.25M | -483.5% |
| Net income to common | -$242.47M | $63.23M | $17.55M | -$86.25M | -483.5% |
| Basic EPS | -4.45 | 1.17 | 0.33 | -1.61 | -480.3% |
| Diluted EPS | -4.45 | 1.16 | 0.32 | -1.61 | -483.6% |
| EBIT | -$171.50M | $151.38M | -$22.37M | -$26.89M | -213.3% |
| EBITDA | -$111.86M | $202.52M | $38.48M | $30.90M | -155.2% |
| Basic shares | 54.50M | 54.20M | 53.90M | 53.50M | +0.6% |
| Diluted shares | 54.50M | 54.60M | 54.20M | 53.50M | -0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $635.55M | $428.86M | $266.50M | $214.17M | +48.2% |
| Cash & short-term investments | $635.55M | $428.86M | $266.50M | $214.17M | +48.2% |
| Accounts receivable | $215.99M | $193.16M | $215.07M | $183.11M | +11.8% |
| Inventory | $164.70M | $147.57M | $147.89M | $129.38M | +11.6% |
| Total current assets | $1.10B | $1.13B | $988.16M | $886.14M | -2.3% |
| Property, plant & equipment | $298.12M | $217.10M | $205.03M | $183.02M | +37.3% |
| Goodwill & intangibles | $1.02B | $987.30M | $1.04B | $1.14B | +3.6% |
| Total assets | $2.61B | $2.51B | $2.43B | $2.29B | +4.0% |
| Total current liabilities | $808.07M | $392.13M | $334.98M | $297.40M | +106.1% |
| Current debt | $31.47M | $78.00M | $18.11M | $23.43M | -59.7% |
| Long-term debt | $345.19M | $549.62M | $568.54M | $518.07M | -37.2% |
| Total debt | $433.77M | $676.77M | $640.40M | $580.43M | -35.9% |
| Total liabilities | $1.41B | $1.19B | $1.15B | $1.09B | +18.5% |
| Retained earnings | -$1.15B | -$903.25M | -$966.48M | -$984.03M | -26.8% |
| Shareholder equity | $1.20B | $1.32B | $1.28B | $1.21B | -9.1% |
| Working capital | $293.54M | $735.06M | $653.17M | $588.74M | -60.1% |
| Net tangible assets | $177.18M | $332.96M | $233.51M | $70.28M | -46.8% |
| Shares issued | 55.54M | 54.44M | 53.94M | 53.85M | +2.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$242.47M | $63.23M | $17.55M | -$86.25M | — | -483.5% |
| Depreciation & amortisation | $59.63M | $51.14M | $60.86M | $57.80M | — | +16.6% |
| Stock-based compensation | $36.29M | $33.93M | $36.35M | $44.81M | — | +7.0% |
| Change in working capital | $369.97M | $1.31M | -$34.62M | -$31.69M | — | +28,228.5% |
| Operating cash flow | $254.34M | $183.04M | $74.91M | $69.92M | — | +39.0% |
| Capital expenditure | -$81.05M | -$47.11M | -$34.98M | -$26.52M | — | -72.1% |
| Investing cash flow | -$72.91M | -$48.16M | -$40.33M | -$38.41M | — | -51.4% |
| Share buybacks | — | -$8.44M | -$7.50M | -$8.67M | -$12.94M | — |
| Financing cash flow | -$285.66M | $18.55M | $21.48M | $280.13M | — | -1,639.9% |
| Free cash flow | $173.29M | $135.93M | $39.93M | $43.40M | — | +27.5% |
| End cash position | $635.55M | $723.56M | $577.87M | $515.62M | — | -12.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $390.59M | $362.26M | $360.92M | $357.75M | $352.52M | +7.8% |
| Operating revenue | $390.59M | $362.26M | $360.92M | $357.75M | $352.52M | +7.8% |
| Cost of revenue | $116.92M | $118.51M | $121.15M | $112.90M | $113.54M | -1.3% |
| Gross profit | $273.67M | $243.75M | $239.77M | $244.85M | $238.99M | +12.3% |
| Research & development | $53.66M | $58.70M | $52.12M | $48.58M | $47.19M | -8.6% |
| Selling, general & admin | $158.13M | $143.57M | $143.37M | $138.52M | $137.78M | +10.1% |
| Total operating expense | $224.19M | $202.28M | $197.19M | $190.84M | $184.81M | +10.8% |
| Operating income | $49.48M | $41.47M | $42.58M | $54.01M | $54.18M | +19.3% |
| Net interest income | -$3.35M | -$4.74M | -$6.40M | -$6.96M | -$10.75M | +29.4% |
| Pre-tax income | $18.48M | $27.48M | $27.63M | $33.91M | $33.32M | -32.8% |
| Tax provision | -$90.20M | $4.34M | -$3.28M | $7.11M | $6.15M | -2,178.4% |
| Net income | $108.57M | $22.29M | $30.91M | $26.78M | $27.16M | +387.0% |
| Net income to common | $108.57M | $22.29M | $30.91M | $26.78M | $27.16M | +387.0% |
| Basic EPS | 1.98 | 0.41 | 0.57 | 0.49 | 0.50 | +382.9% |
| Diluted EPS | 1.93 | 0.40 | 0.56 | 0.49 | 0.50 | +382.5% |
| EBIT | $25.66M | $35.78M | $38.49M | $44.77M | $48.25M | -28.3% |
| EBITDA | $43.85M | $51.37M | $53.20M | $59.99M | $63.29M | -14.6% |
| Basic shares | 55.00M | 54.70M | 54.60M | 54.60M | 54.60M | +0.5% |
| Diluted shares | 56.30M | 55.90M | 55.50M | 55.20M | 54.70M | +0.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $516.62M | $539.71M | $635.55M | $646.08M | $593.64M | -4.3% |
| Cash & short-term investments | $516.62M | $539.71M | $635.55M | $646.08M | $593.64M | -4.3% |
| Accounts receivable | $231.30M | $229.27M | $215.99M | $211.58M | $220.19M | +0.9% |
| Inventory | $172.61M | $165.50M | $164.70M | $167.54M | $165.35M | +4.3% |
| Total current assets | $1.03B | $1.01B | $1.10B | $1.10B | $1.07B | +1.1% |
| Property, plant & equipment | $330.05M | $310.01M | $298.12M | $269.71M | $246.09M | +6.5% |
| Goodwill & intangibles | $996.15M | $1.01B | $1.02B | $1.03B | $1.03B | -1.4% |
| Total assets | $2.64B | $2.52B | $2.61B | $2.56B | $2.51B | +4.9% |
| Total current liabilities | $707.00M | $762.48M | $808.07M | $827.59M | $827.10M | -7.3% |
| Current debt | $3.58M | $2.63M | $31.47M | $85.44M | $82.13M | +36.3% |
| Long-term debt | $289.91M | $285.16M | $345.19M | $349.03M | $348.49M | +1.7% |
| Total debt | $351.95M | $343.44M | $433.77M | $486.55M | $482.78M | +2.5% |
| Total liabilities | $1.32B | $1.31B | $1.41B | $1.40B | $1.38B | +0.8% |
| Retained earnings | -$1.01B | -$1.12B | -$1.15B | -$1.18B | -$1.20B | +9.7% |
| Shareholder equity | $1.33B | $1.21B | $1.20B | $1.16B | $1.12B | +9.4% |
| Working capital | $318.04M | $251.76M | $293.54M | $269.56M | $239.04M | +26.3% |
| Net tangible assets | $329.18M | $201.18M | $177.18M | $131.67M | $90.33M | +63.6% |
| Shares issued | 55.05M | 55.54M | 55.54M | 55.50M | 55.50M | -0.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $108.57M | $22.29M | $30.91M | $26.78M | $27.16M | +387.0% |
| Depreciation & amortisation | $18.20M | $15.60M | $14.71M | $15.21M | $15.04M | +16.7% |
| Stock-based compensation | $16.88M | $8.27M | $9.39M | $9.95M | $9.17M | +104.1% |
| Change in working capital | -$18.23M | -$60.29M | $19.13M | $8.31M | $6.45M | +69.8% |
| Operating cash flow | $66.59M | $15.22M | $82.40M | $85.06M | $62.92M | +337.6% |
| Capital expenditure | -$31.55M | -$14.29M | -$32.23M | -$22.88M | -$15.15M | -120.8% |
| Investing cash flow | -$31.92M | -$14.58M | -$30.26M | -$23.06M | -$8.97M | -118.9% |
| Financing cash flow | -$56.45M | -$94.25M | -$62.88M | -$9.37M | -$208.98M | +40.1% |
| Free cash flow | $35.04M | $926.00K | $50.16M | $62.18M | $47.77M | +3,683.8% |
| End cash position | $516.62M | $539.71M | $635.55M | $646.08M | $593.64M | -4.3% |
Options analytics
Put / call volume
0.09
Call-heavy session
Put / call open interest
0.55
Positioning, not flow
Max pain
75.00
+0.1% from spot
ATM implied vol
79.5%
Nearest strike to spot
Skew (10% OTM)
+6.0%
Puts bid over calls
Call volume
55
Contracts, this expiry
Put volume
5
Contracts, this expiry
Heaviest call OI
75.00
5 contracts
Heaviest put OI
75.00
4 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.09 | 1.26 | +15.1% |
| Mar 2026 | 0.90 | 0.98 | +9.3% |
| Dec 2025 | 0.81 | 0.86 | +5.6% |
| Sep 2025 | 0.92 | 1.11 | +20.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.06 | 9 | $381.10M | +6.5% |
| Next quarter | 1.06 | 9 | $390.26M | +8.1% |
| Current year | 4.36 | 9 | $1.52B | +9.6% |
| Next year | 4.68 | 9 | $1.63B | +7.1% |
Analyst targets & ownership
Mean target$89.10
High target$100.00
Low target$75.00
Implied upside18.91%
Analyst count10
ConsensusNONE
Strong buy / Buy2 / 6
Hold2
Sell / Strong sell0 / 0
Held by insiders0.41%
Held by institutions112.89%
Institutions holding449
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
76.11
-1.55% from price
SMA 20
77.37
-3.15% from price
SMA 50
79.07
-5.24% from price
SMA 100
78.55
-4.61% from price
SMA 200
71.48
+4.83% from price
EMA 12
76.44
-1.97% from price
EMA 26
77.56
-3.39% from price
EMA 50
78.13
-4.09% from price
RSI (14)
39.7
Neutral
MACD (12,26,9)
-1.12
Hist -0.20
ATR (14)
2.14
2.85% of price
Realised vol 30D
22.5%
Annualised
Bollinger upper
80.44
20, 2σ
Bollinger lower
74.30
20, 2σ
50 / 200 cross
Golden
79.07 vs 71.48
Trend bias
Above 200
+4.83%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.99
Less volatile than market
Correlation to SPY
0.36
Loosely linked
Realised vol 30D
22.5%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-18.9%
Peak to trough
Max drawdown 5Y
-63.5%
Peak to trough
ATR 14
2.14
2.85% of price
Beta (reported)
0.88
5Y monthly, from filing
Short interest
Shares short
5.38M
Prior 4.72M
Change vs prior
+13.9%
Shorts adding
% of float
11.20%
Elevated
% of shares out
9.76%
Against total outstanding
Days to cover
9.5
Crowded exit
Float
54.84M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 2, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Aug 5, 26 | Needham | MAINTAINED | Buy | Buy |
| Jul 15, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Jul 1, 26 | Freedom Capital Markets | INITIATED | — | Hold |
| Jun 22, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| May 7, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| May 7, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| May 7, 26 | Baird | MAINTAINED | Outperform | Outperform |
| Feb 27, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Feb 25, 26 | Needham | MAINTAINED | Buy | Buy |
| Jan 9, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Jan 7, 26 | Stifel | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-Q · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-06-11
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-29
Periodic Financial Reports
10-Q · 2026-05-06
Annual Report to Shareholders
ARS · 2026-04-29
Periodic Financial Reports
10-K · 2026-02-25
Corporate Changes & Voting Matters
8-K · 2026-01-14
Corporate Changes & Voting Matters
8-K · 2025-11-05
Headlines
Operating Leverage and Product Innovation Drive LivaNova’s(LIVN) Sustained Profit Outlook
Insider Monkey · 13d ago
LivaNova to Announce Third-Quarter 2026 Results
Business Wire · 14d ago
Livanova Insider Sold Shares Worth $273,032, According to a Recent SEC Filing
MT Newswires · 22d ago
LivaNova Director Sells 1,650 Shares for $131,500
Motley Fool · 26d ago
GHO Capital appoints Vivid Sehgal as Operating Partner
GlobeNewswire · 29d ago
LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September
Business Wire · 34d ago
NeuroPace Faces an IGE Delay: What the FDA Setback Means for Growth
Zacks · 50d ago
Is NeuroPace a Buy as Growth Improves but Valuation Stays Elevated?
Zacks · 50d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.